Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wouter Peelaerts

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Neurochemistry|March 1, 2016
ɑ-Synuclein strains and the variable pathologies of synucleinopathiesWouter Peelaerts, Veerle Baekelandt
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 13, 2023
⍺-Synuclein Structural Diversity and the Cellular Environment in ⍺-Synuclein Transmission Models and HumansWouter Peelaerts, Veerle Baekelandt
Journal of Neural Transmission (Vienna, Austria : 1996)|October 6, 2021
A historical review of multiple system atrophy with a critical appraisal of cellular and animal modelsDavid J Marmion, Wouter Peelaerts, Jeffrey H Kordower
Journal of Parkinson'S Disease|September 27, 2024
Infections in the Etiology of Parkinson's Disease and Synucleinopathies: A Renewed Perspective, Mechanistic Insights, and Therapeutic ImplicationsGabriela Mercado, Christopher Kaeufer, Franziska Richter, et al.
Progress in Molecular Biology and Translational Science|November 9, 2019
Can infections trigger alpha-synucleinopathies?Christopher T Tulisiak, Gabriela Mercado, Wouter Peelaerts, et al.
Molecular Neurodegeneration|May 26, 2018
Targeting energy metabolism via the mitochondrial pyruvate carrier as a novel approach to attenuate neurodegenerationEmmanuel Quansah, Wouter Peelaerts, J William Langston, et al.
Human Gene Therapy|May 19, 2021
Widespread, Specific, and Efficient Transgene Expression in Oligodendrocytes After Intracerebral and Intracerebroventricular Delivery of Viral Vectors in Rodent BrainWouter Peelaerts, Filipa Brito, Chris Van den Haute, et al.
Acta Neuropathologica|May 2, 2020
The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodiesAnke Van der Perren, Géraldine Gelders, Alexis Fenyi, et al.
Journal of Parkinson'S Disease|February 17, 2025
Chronic urinary tract infections cause persistent microglial changes in a humanized ɑ-synuclein mouse modelGabriela Mercado, Ann-Céline Clabout, Vanessa Howland, et al.
Brain : a Journal of Neurology|February 16, 2022
Host oligodendrogliopathy and α-synuclein strains dictate disease severity in multiple system atrophyTeresa Torre-Muruzabal, Anke Van der Perren, Audrey Coens, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Neurochemistry|March 1, 2016
ɑ-Synuclein strains and the variable pathologies of synucleinopathiesWouter Peelaerts, Veerle Baekelandt
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 13, 2023
⍺-Synuclein Structural Diversity and the Cellular Environment in ⍺-Synuclein Transmission Models and HumansWouter Peelaerts, Veerle Baekelandt
Journal of Neural Transmission (Vienna, Austria : 1996)|October 6, 2021
A historical review of multiple system atrophy with a critical appraisal of cellular and animal modelsDavid J Marmion, Wouter Peelaerts, Jeffrey H Kordower
Journal of Parkinson'S Disease|September 27, 2024
Infections in the Etiology of Parkinson's Disease and Synucleinopathies: A Renewed Perspective, Mechanistic Insights, and Therapeutic ImplicationsGabriela Mercado, Christopher Kaeufer, Franziska Richter, et al.
Progress in Molecular Biology and Translational Science|November 9, 2019
Can infections trigger alpha-synucleinopathies?Christopher T Tulisiak, Gabriela Mercado, Wouter Peelaerts, et al.
Molecular Neurodegeneration|May 26, 2018
Targeting energy metabolism via the mitochondrial pyruvate carrier as a novel approach to attenuate neurodegenerationEmmanuel Quansah, Wouter Peelaerts, J William Langston, et al.
Human Gene Therapy|May 19, 2021
Widespread, Specific, and Efficient Transgene Expression in Oligodendrocytes After Intracerebral and Intracerebroventricular Delivery of Viral Vectors in Rodent BrainWouter Peelaerts, Filipa Brito, Chris Van den Haute, et al.
Acta Neuropathologica|May 2, 2020
The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodiesAnke Van der Perren, Géraldine Gelders, Alexis Fenyi, et al.
Journal of Parkinson'S Disease|February 17, 2025
Chronic urinary tract infections cause persistent microglial changes in a humanized ɑ-synuclein mouse modelGabriela Mercado, Ann-Céline Clabout, Vanessa Howland, et al.
Brain : a Journal of Neurology|February 16, 2022
Host oligodendrogliopathy and α-synuclein strains dictate disease severity in multiple system atrophyTeresa Torre-Muruzabal, Anke Van der Perren, Audrey Coens, et al.
Pageof 2